PerkinElmer – Consensus Indicates Potential 22.4% Upside
PerkinElmer with ticker code (PKI) now have 12 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 200 and 125 and has a mean target at 171.25. Given that the stocks previous close was at 139.92 this now indicates there is a potential upside of 22.4%. The 50 day moving average now sits at 143.44 and the 200 day MA is 167.53. The company has a market capitalisation of $18,665m. Company Website: https:||www.perkinelmer.com [stock_market_widget type="chart" template="basic" color="green" assets="PKI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $22,844m based on the market concensus. PerkinElmer provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery Analytical Solutions and Diagnostics. The Discovery Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.
PerkinElmer – Consensus Indicates Potential 22.4% Upside
PerkinElmer with ticker code (PKI) now have 12 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 200 and 125 and has a mean target at 171.25. Given that the stocks previous close was at 139.92 this now indicates there is a potential upside of 22.4%. The 50 day moving average now sits at 143.44 and the 200 day MA is 167.53. The company has a market capitalisation of $18,665m. Company Website: https:||www.perkinelmer.com [stock_market_widget type="chart" template="basic" color="green" assets="PKI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $22,844m based on the market concensus. PerkinElmer provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery Analytical Solutions and Diagnostics. The Discovery Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.